ES2139363T3 - Nuevos peptidos para uso en el tratamiento de la destruccion del cartilago mediada por celulas t en enfermedades autoinmunes. - Google Patents
Nuevos peptidos para uso en el tratamiento de la destruccion del cartilago mediada por celulas t en enfermedades autoinmunes.Info
- Publication number
- ES2139363T3 ES2139363T3 ES96920822T ES96920822T ES2139363T3 ES 2139363 T3 ES2139363 T3 ES 2139363T3 ES 96920822 T ES96920822 T ES 96920822T ES 96920822 T ES96920822 T ES 96920822T ES 2139363 T3 ES2139363 T3 ES 2139363T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- cartilage
- cells
- peptides
- autoimmune diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000006378 damage Effects 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
LA INVENCION ESTA RELACIONADA CON EL EMPLEO DE NUEVOS PEPTIDOS EN UN TRATAMIENTO DE TOLERANCIA INDUCIDA POR PEPTIDOS, PARA LA INDUCCION DE TOLERANCIA A LAS CELULAS T AUTOAGRESIVAS ASOCIADAS A LA DESTRUCCION DE CARTILAGO ARTICULAR MEDIADA POR CELULAS T EN ENFERMEDADES AUTOINMUNES, ESPECIFICAMENTE LA ARTRITIS. LA INVENCION TAMBIEN ABARCA COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN LOS PEPTIDOS CITADOS Y UN METODO DIAGNOSTICO PARA LA DETECCION DE CELULAS T AUTORREACTIVAS EN UNA MUESTRA PROBLEMA, LAS CELULAS T CITADAS QUE SE ASOCIAN A LA DESTRUCCION DE CARTILAGO ARTICULAR MEDIADA POR CELULAS T EN ENFERMEDADES AUTOINMUNES Y EQUIPOS DE ANALISIS PARA UTILIZAR EN EL METODO CITADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95201656 | 1995-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2139363T3 true ES2139363T3 (es) | 2000-02-01 |
Family
ID=8220392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96920822T Expired - Lifetime ES2139363T3 (es) | 1995-06-19 | 1996-06-17 | Nuevos peptidos para uso en el tratamiento de la destruccion del cartilago mediada por celulas t en enfermedades autoinmunes. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0833842B1 (es) |
JP (1) | JPH11507919A (es) |
KR (1) | KR19990022972A (es) |
CN (1) | CN1155617C (es) |
AT (1) | ATE185151T1 (es) |
AU (1) | AU704942B2 (es) |
BR (1) | BR9608626A (es) |
CA (1) | CA2221981A1 (es) |
DE (1) | DE69604492T2 (es) |
DK (1) | DK0833842T3 (es) |
ES (1) | ES2139363T3 (es) |
GR (1) | GR3031990T3 (es) |
HU (1) | HU223275B1 (es) |
IL (1) | IL118524A (es) |
MX (1) | MX9710508A (es) |
NO (1) | NO975968L (es) |
NZ (1) | NZ311022A (es) |
PL (1) | PL185258B1 (es) |
TR (1) | TR199701658T1 (es) |
WO (1) | WO1997000270A1 (es) |
ZA (1) | ZA965163B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
MEP42108A (en) | 1998-10-23 | 2011-02-10 | Kiren Amgen Inc | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
IL132611A0 (en) | 1999-10-27 | 2001-03-19 | Yeda Res & Dev | Synthetic genes and polypeptides and pharmaceutical compositions comprising them |
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
-
1996
- 1996-05-31 IL IL11852496A patent/IL118524A/en not_active IP Right Cessation
- 1996-06-17 AT AT96920822T patent/ATE185151T1/de not_active IP Right Cessation
- 1996-06-17 DK DK96920822T patent/DK0833842T3/da active
- 1996-06-17 JP JP9502649A patent/JPH11507919A/ja not_active Ceased
- 1996-06-17 BR BR9608626A patent/BR9608626A/pt not_active Application Discontinuation
- 1996-06-17 ES ES96920822T patent/ES2139363T3/es not_active Expired - Lifetime
- 1996-06-17 WO PCT/EP1996/002605 patent/WO1997000270A1/en not_active Application Discontinuation
- 1996-06-17 CN CNB961948698A patent/CN1155617C/zh not_active Expired - Fee Related
- 1996-06-17 TR TR97/01658T patent/TR199701658T1/xx unknown
- 1996-06-17 AU AU62246/96A patent/AU704942B2/en not_active Ceased
- 1996-06-17 KR KR1019970709442A patent/KR19990022972A/ko not_active Application Discontinuation
- 1996-06-17 PL PL96324208A patent/PL185258B1/pl not_active IP Right Cessation
- 1996-06-17 NZ NZ311022A patent/NZ311022A/xx unknown
- 1996-06-17 CA CA002221981A patent/CA2221981A1/en not_active Abandoned
- 1996-06-17 MX MX9710508A patent/MX9710508A/es not_active IP Right Cessation
- 1996-06-17 HU HU9802197A patent/HU223275B1/hu not_active IP Right Cessation
- 1996-06-17 DE DE69604492T patent/DE69604492T2/de not_active Expired - Fee Related
- 1996-06-17 EP EP96920822A patent/EP0833842B1/en not_active Expired - Lifetime
- 1996-06-18 ZA ZA965163A patent/ZA965163B/xx unknown
-
1997
- 1997-12-18 NO NO975968A patent/NO975968L/no not_active Application Discontinuation
-
1999
- 1999-11-30 GR GR990403083T patent/GR3031990T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1155617C (zh) | 2004-06-30 |
NO975968D0 (no) | 1997-12-18 |
HUP9802197A3 (en) | 1999-06-28 |
NO975968L (no) | 1997-12-18 |
TR199701658T1 (xx) | 1998-06-22 |
CA2221981A1 (en) | 1997-01-03 |
DE69604492D1 (de) | 1999-11-04 |
EP0833842A1 (en) | 1998-04-08 |
AU704942B2 (en) | 1999-05-06 |
IL118524A0 (en) | 1996-09-12 |
PL185258B1 (pl) | 2003-04-30 |
GR3031990T3 (en) | 2000-03-31 |
HU223275B1 (hu) | 2004-04-28 |
WO1997000270A1 (en) | 1997-01-03 |
ATE185151T1 (de) | 1999-10-15 |
HUP9802197A2 (hu) | 1999-02-01 |
CN1188483A (zh) | 1998-07-22 |
DK0833842T3 (da) | 2000-04-03 |
KR19990022972A (ko) | 1999-03-25 |
JPH11507919A (ja) | 1999-07-13 |
NZ311022A (en) | 1999-11-29 |
PL324208A1 (en) | 1998-05-11 |
ZA965163B (en) | 1997-01-23 |
IL118524A (en) | 2004-02-19 |
MX9710508A (es) | 1998-03-31 |
BR9608626A (pt) | 1999-06-15 |
AU6224696A (en) | 1997-01-15 |
DE69604492T2 (de) | 2000-04-13 |
EP0833842B1 (en) | 1999-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2145451T3 (es) | Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas. | |
ES2077104T3 (es) | Protesis de polimero de uretano policarbonato resistentes a la fractura y similares. | |
EA199900474A1 (ru) | Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина | |
DK187089D0 (da) | Steril beholder til opsamling af biologiske proever til brug ved analyser | |
ES2139363T3 (es) | Nuevos peptidos para uso en el tratamiento de la destruccion del cartilago mediada por celulas t en enfermedades autoinmunes. | |
EA200000298A1 (ru) | Агонисты простагландинов и их применение для лечения заболеваний костей | |
ATE423788T1 (de) | Neues tgf-beta-ahnliches cytokin | |
ES2196082T3 (es) | Analagos del factor de crecimiento de queratinocitos. | |
ES2155651T3 (es) | Cilindros de doble apertura y procedimiento correspondiente de apertura y limpieza de fibras cortadas. | |
HUP9901375A2 (hu) | Antigénspecifikus immunszupressziós génterápiában alkalmazható új peptidek | |
ES2151544T3 (es) | Metodos para la deteccion y el tratamiento de individuos con celulas anormales que expresan antigenos peptidos hla-a2/tirosinasa. | |
AR008781A1 (es) | Compuestos de furano nitrona | |
AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
AR027694A1 (es) | Uso de la proteina mia para el tratamiento de enfermedades autoinmunes | |
MX9400799A (es) | Dispositivo para la recoleccion de sangre. | |
BR0114977A (pt) | segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos | |
ES2084668T3 (es) | Procedimiento. | |
TR200100175T2 (tr) | Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. | |
DK0883406T3 (da) | Anvendelse af IL-7 til behandling af autoimmune sygdomme og især insulinafhængig diabe-tesmellitus i særdeleshed | |
ECSP993062A (es) | Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea | |
ES2121204T3 (es) | Preparacion de fluoro-nucleosidos e intermedios para su uso en ella. | |
AR016052A1 (es) | Un metodo para diferenciar entre las variantes 2a y 2b de interferon alfa | |
ES2113333T1 (es) | Peptidos que reaccionan con anticuerpos que representan el marcador de pronostico de la progresion de la enfermedad del sida. | |
ES2136534B1 (es) | Uso de la w-1 secalina para la deteccion y seguimiento de la enfermedad celiaca. | |
ES2053081T3 (es) | Nuevo procedimiento para desecho de los residuos que se derivan de los procedimientos de sintesis de hidrocarburos clorados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 833842 Country of ref document: ES |